SPC244
Erenúmab
Status:
VeittApplication date:
10.12.2018Application published:
15.1.2019Grant published:
15.9.2020
Max expiry date:
29.7.2033Medicine name:
AimovigMedicine for children:
No
Timeline
Today
10.12.2018Application
15.1.2019Publication
15.9.2020Registration
29.7.2033Expires
Marketing license
IS authorization number:
EU/1/18/1293/001-002; EU/1/18/1293/003Date:
16.8.2018
Foreign authorization number:
EU/1/18/1293Date:
26.7.2018
Owner
Name:
Amgen, Inc.Address:
One Amgen Center Drive, Thousand Oaks US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2379594